Cargando…
Landscape of immune checkpoint inhibitor-related adverse events in Chinese population
This study aimed to describe the landscape of Immune checkpoint inhibitors (ICIs)-related adverse events (AEs) in a predominantly Chinese cohort. We searched electronic datasets including PubMed, Web of Science and Embase to identify and recruit relevant trials up to September 2, 2019. Clinical tria...
Autores principales: | Li, Li, Li, Gang, Rao, Bin, Dong, An-Hui, Liang, Wei, Zhu, Jin-Xian, Qin, Mu-Ping, Huang, Wen-Wen, Lu, Jie-Ming, Li, Zi-Fang, Wu, Yao-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511303/ https://www.ncbi.nlm.nih.gov/pubmed/32968172 http://dx.doi.org/10.1038/s41598-020-72649-5 |
Ejemplares similares
-
Management of immune checkpoint inhibitor‐related rheumatic adverse events
por: Zhou, Jiaxin, et al.
Publicado: (2019) -
Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
por: Xiao, Yan, et al.
Publicado: (2020) -
Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019) -
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
por: Jia, Xiao-Hui, et al.
Publicado: (2020) -
Management of immune checkpoint inhibitor‐related dermatologic adverse events
por: Si, Xiaoyan, et al.
Publicado: (2019)